ETF DAILY NEWS

Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by TD Cowen

Research analysts at TD Cowen assumed coverage on shares of Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) in a research report issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating on the stock. DRUG has been the topic of a number of other research reports. Piper Sandler initiated coverage on shares of […]

May 15, 2025 - 09:10
 0
Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by TD Cowen
Research analysts at TD Cowen assumed coverage on shares of Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) in a research report issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating on the stock. DRUG has been the topic of a number of other research reports. Piper Sandler initiated coverage on shares of […]
Read More

Tags:

Previous Article

Apollo Management Holdings Gp, Sells 50,000,000 Shares of ADT Inc. (NYSE:ADT) Stock

Next Article

Loop Capital Cuts FAT Brands (NASDAQ:FAT) Price Target to $10.00

Related Posts

Hudson Pacific Properties, Inc. (NYSE:HPP) Shares Sold by Hsbc Holdings PLC

Hudson Pacific Properties, Inc. (NYSE:HPP) Shares Sold ...

May 11, 2025  0

Reading International (NASDAQ:RDI) Coverage Initiated at StockNews.com

Reading International (NASDAQ:RDI) Coverage Initiated a...

May 15, 2025  0

NWTN (NASDAQ:NWTN) Trading 13.1% Higher – Still a Buy?

NWTN (NASDAQ:NWTN) Trading 13.1% Higher – Still a Buy?

May 14, 2025  0